Hypoglycemia laboratory findings

Revision as of 20:15, 13 July 2017 by Medhat (talk | contribs)
Jump to navigation Jump to search

Hypoglycemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypoglycemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypoglycemia laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypoglycemia laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypoglycemia laboratory findings

CDC on Hypoglycemia laboratory findings

Hypoglycemia laboratory findings in the news

Blogs on Hypoglycemia laboratory findings

Directions to Hospitals Treating Hypoglycemia

Risk calculators and risk factors for Hypoglycemia laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Laboratory Findings

Defining Hypoglycemia

Hypoglycemia can't be diagnosed only according to blood glucose level because it is misleading maneuver with high false positive results.The measurement should be repeated using a collection tube that contains an inhibitor of glycolysis and processing should not be delayed.

So, Dependence on three characters to diagnose hypoglycemia is the accepted method. It is called Whipple's triad which includes

  • Symptoms of hypoglycemia
  • A low plasma glucose concentration corellated with symptoms.
  • Correction of glucose level relieves symptoms.

Strategy is to seek Whipple's triad under conditions in which hypoglycemia would be expected:

  • If the symptoms occur in the fasting state, that evaluation should be performed during fasting.
  • If there is a compelling history of postprandial symptoms, it is reasonable to seek Whipple's triad with frequent, timed plasma glucose measurements and recording of any symptoms after a mixed meal.
  • All of the following should be measured:
  • Glucose: plasma glucose should be <55 mg/dL.
  • Insulin
  • C-peptide
  • Proinsulin
  • Sulfonylurea and meglitinide screen
  • Beta-hydroxybutyrate

Fasting evaluation:

  • If prolonged fasting may result in an episode of symptomatic hypoglycemia, plasma glucose should be measured repeatedly during fasting.
  • If symptoms occur and hypoglycemia is documented, the other tests mentioned above should be performed.
  • If the results are equivocal so patient needs another confirmatry test such as the 72-hour fast.

Mixed-meal evaluation:

  • If symptoms appear within 5 hours after meals, we should suspect postprandial hypoglycemia.[2]
  • Recurrent sampling before and after meals for the following 5 hours will help diagnosis; If severe symptoms occur, the samples for glucose should be analyzed.
  • If Whipple's triad is demonstrated, sulfonylureas, meglitinides, and antibodies to insulin should also be measured.

24-hour fasting

  • Increased release of glucagon, epinephrine and cortisol is the most important factors that keep blood glucose concentrations from falling during fasting.
  • Gluconeogenesis is the most important factor of glucose production after prolonged fast[4].
  • If there is high level of insulin, gluconeogenesis will be inhibited causing hypoglycemia during fasting.

The fast is ended when: [1,2]

  • 72 hours have passed
  • Plasma glucose concentration is ≤45 mg/dL
  • Patient has symptoms or signs of hypoglycemia

The precise level of glucose considered low enough to define hypoglycemia is dependent on (1) the measurement method, (2) the age of the person, (3) presence or absence of effects, and (4) the purpose of the definition. While there is no disagreement as to the normal range of blood sugar, debate continues as to what degree of hypoglycemia warrants medical evaluation or treatment, or can cause harm.[1][2][3]

Age Differences

Surveys of healthy children and adults show that plasma glucoses below 60 mg/dL (3.3 mM) or above 100 mg/dL (5.6 mM) are found in less than 5% of samples after an overnight fast.[4] In infants and young children up to 10% have been found to be below 60 mg/dL after an overnight fast. As the duration of fasting is extended, plasma glucose levels can fall further, even in healthy people. In other words, many healthy people can occasionally have glucose levels in the hypoglycemic range without symptoms or disease.

The normal range of newborn blood sugars continues to be debated. Surveys and experience have revealed blood sugars often below 40 mg/dL (2.2 mM), rarely below 30 mg/dL (1.7 mM) in apparently healthy full-term infants on the first day after birth. It has been proposed that newborn brains are able to use alternate fuels when glucose levels are low more readily than adults. Experts continue to debate the significance and risk of such levels, though the trend has been to recommend maintenance of glucose levels above 60-70 mg/dL after the first day after birth. In ill, undersized, or premature newborns, low blood sugars are even more common, but there is a consensus that sugars should be maintained at least above 50 mg/dL (2.8 mM) in such circumstances. Some experts advocate 70 mg/dL as a therapeutic target, especially in circumstances such as hyperinsulinism where alternate fuels may be less available.

References

  1. Koh TH, Eyre JA, Aynsley-Green A (1988). "Neonatal hypoglycaemia--the controversy regarding definition". Arch. Dis. Child. 63 (11): 1386–8. PMID 3202648.
  2. Cornblath M, Schwartz R, Aynsley-Green A, Lloyd JK (1990). "Hypoglycemia in infancy: the need for a rational definition. A Ciba Foundation discussion meeting". Pediatrics. 85 (5): 834–7. PMID 2330247.
  3. Cornblath M, Hawdon JM, Williams AF, Aynsley-Green A, Ward-Platt MP, Schwartz R, Kalhan SC (2000). "Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds". Pediatrics. 105 (5): 1141–5. PMID 10790476.
  4. Samuel Meites, editor-in-chief; contributing editors, Gregory J. Buffone... [et al.] (1989). Pediatric clinical chemistry: reference (normal) values. Washington, D.C: AACC Press. ISBN 0-915274-47-7.


Template:WikiDoc Sources